PROLIXIN DECANOATE Reviews

Average Rating: 2.3 (3 Ratings)

Filter Results

Compare PROLIXIN DECANOATE with similar:
 ANTIPSYCHOTICS ANTIMANICS

 Type: Brand name discontinued; available as generic
  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR PROLIXIN DECANOCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  Schizophrenia Severe shaking in my legs. I could not sit or lay down. I could not drink or eat. Severe dehydration and I could not walk. Liver failure on this medicine. I was given Benadryl to counteract this medicine to help the severe shaking in my legs. And Artane. F 42 6 weeks
12.5 mg
5/9/2017
 1  Because the psychiatrist said I experienced seizure of the mouth and jaw. Upon struggling to breathe or swallow, I was met with laughter and thirst and giggles and smiles It is painful to take F 31 10 years
12/22/2016
Email
 5  
12/17/2007
  

PROLIXIN DECANOATE  (FLUPHENAZINE DECANOATE):  This medication is a long-acting form of fluphenazine that is used to treat certain mental/mood problems (chronic schizophrenia). Fluphenazine decanoate is usually used in patients who have benefited from regular doses of short-acting forms of fluphenazine and who may benefit from long-term (maintenance) treatment with less frequent dosing. Fluphenazine belongs to a class of medications called phenothiazines and is also referred to as a neuroleptic. It works by affecting the balance of natural chemicals (neurotransmitters) in the brain. Some of the benefits of continued use of this medication include reduced episodes of hallucinations, delusions, or bizarre behaviors that occur in patients with schizophrenia. This product does not work right away. It may take 1-3 days to notice an effect from this drug, and up to 4 days to experience the full effect. For severe agitation or other symptoms, use a short-acting medication as directed by your doctor. This medication is not recommended for use in children under 12 years of age. Also, it should not be used to manage behavioral problems in patients with mental retardation.   (Sources: U.S. Centers for Medicare Services, FDA)

BACK TO TOP